|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| C07K 14/725 | (2006.01) | ||
| C12N 5/0783 | (2010.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3880802 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19821337.3 |
| Date of filing the European patent application | 2019-11-15 | |
| (97) | Date of publication of the European application | 2021-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2022-09-07 |
| (46) | Date of publication of the claims translation | 2022-12-12 |
| (86) | Number | PCT/US2019/061723 |
| Date | 2019-11-15 |
| (87) | Number | WO 2020/102676 |
| Date | 2020-05-22 |
| (30) | Number | Date | Country code |
| 201862768579 P | 2018-11-16 | US |
| (72) |
BRIEVA, Thomas, A. , US
HSIUNG, David , US
JONES, Seth , US
MISTRY, Shiv , US
RAJAEI, Nayyereh , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Patobulintas T ląstelių gamybos būdas |
| IMPROVED T CELL MANUFACTURING PROCESS |
| Payment date | Validity (years) | Amount | |
| 2024-10-04 | 6 | 139.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2025-04-03 |